Treatment of urinary tract infections. Open comparative trial.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001437:Bacteriuria / Q000175:diagnosis; D002908:Chronic Disease; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000302:isolation & purification; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009582:Nitrofurantoin / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D009582:Nitrofurantoin; D013752:Tetracycline; D013420:Sulfamethoxazole